Pseudonymization of patient identifiers for trans-lational research
The usage of clinical patient data for research im-poses risks concerning privacy and informational self-determination of the patient. The gold standard for safeguarding patients' personal rights is the anonymization of the clinical data. However, next-generation-sequencing technologies and various other methods impose ethical constraints that pro-hibit anonymization of patient samples. Individual results from genetic and genomic research should be offered to study participants in a timely manner. A new method for pseudonymizing patient identifi-ers is presented in which the pseudonymization service provider is unable to derive the patient iden-tifier from the pseudonym, but rather this ability is assigned to an authorized third party (Ombuds-man).
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Bringing bio-inspired robots to life
Nebraska researcher Eric Markvicka gets NSF CAREER Award to pursue manufacture of novel materials for soft robotics and stretchable electronics. Engineers are increasingly eager to develop robots that mimic the…
Bella moths use poison to attract mates
Scientists are closer to finding out how. Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. They’re produced by several different types of plants and are…
AI tool creates ‘synthetic’ images of cells
…for enhanced microscopy analysis. Observing individual cells through microscopes can reveal a range of important cell biological phenomena that frequently play a role in human diseases, but the process of…